Metcela Inc. | Revolutionizing the Way We Treat Heart Failure > NEWS > Leadership Transition

NEWS

2024.07.01

Leadership Transition | Metcela Inc.

Metcela announces changes in executive leadership as follows.

Name	New Position	Previous Position
Kohtaro Toda	CEO	Senior VP of Business Development JRM-001 Project Leader
Takahiro Iwamiya	Resigned	co-CEO
Kenichi Nogami	Resigned	co-CEO

MEDIA

2025.09.30

An interview with our CEO, Kohtaro Toda, has been published in Nikkei Biotechnology & Business Online (in Japanese)
PRESENTATION

2025.09.25

Our CEO, Kohtaro Toda, will present “The Realities of Utilizing a CDMO” at the J-TEC CDMO Seminar (in Japanese)
PRESS RELEASE

2025.02.25

Metcela Resumes Phase 3 Clinical Trials of Cell Product JRM-001 for Patients with Functional Single Ventricle
NEWS

2024.07.01

Leadership Transition

News archive